Brief: EcoR1 Capital Reports 11.7% Passive Stake In TScan Therapeutics
05/06/2023 22:06
June 5 (Reuters) - TScan Therapeutics Inc TCRX.O :
* ECOR1 CAPITAL, LLC REPORTS 11.7% PASSIVE STAKE IN TSCAN
THERAPEUTICS, INC. AS OF MAY 26, 2023- SEC FILING
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing